跳至主要内容
临床试验/NCT02299882
NCT02299882Unknown不适用

Surgical Infection Rates With Adjunct Vancomycin Compared to Standard Peri-Operative IV Antibiotics

Spectrum Health Hospitals1 个研究点 分布在 1 个国家目标入组 700 人开始时间: 2012年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
700
试验地点
1
主要终点
Surgical wound infection rate, both deep and superficial infections

研究概览

简要总结

Determine the effect of Vancomycin Powder added to the surgical wound at closure on surgical infection rates.

详细描述

Study will be blinded and randomized 1:1 to either Vancomycin Powder at closure or no vancomycin powder at closure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All adult, 18 years or greater undergoing posterior approach spinal surgery

排除标准

  • Prisoner, pregnant women, patient under the age of 18, those of diminished decision making capacity.
  • patients with known reaction to Vancomycin.
  • patients having surgery specifically for spine infection
  • patients having ADCF or ALIF

研究组 & 干预措施

Vancomycin

Experimental

Patient will receive Vancomycin powder to the incision just before skin closure

干预措施: Vancomycin (Drug)

结局指标

主要结局

Surgical wound infection rate, both deep and superficial infections

时间窗: 12 weeks post surgery

次要结局

  • Post-operative rate of MRSA infections.(12 weeks post surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jason A Squires, DO

Physician

Spectrum Health Hospitals

研究点 (1)

Loading locations...

相似试验

Surgical Infection Rates With Adjunct Vancomycin... | 临床试验